Xadago (safinamide) Is Leading New Hope For Parkinson’s Disease Treatment
Parkinson’s Disease (PD) is a complex neurodegenerative disease that affects the quality of life of…
Articles
Pretomanid 200 mg Receives EMA Recommendation For Approval, Offering Hope For Drug-Resistant TB Patients
Pretomanid 200 mg tablets are a novel nitroimidazooxazine-based anti-tuberculosis drug that kills Mycobacterium tuberculosis by…
Izervay (Avacincaptad Pegol) Explained: Mechanism of Action, Benefits & Side Effects
Introduction Izervay (Avacincaptad Pegol) is a groundbreaking treatment approved for geographic atrophy (GA), an advanced…
Zepzelca (Lurbinectedin): New Hope For Small Cell Lung Cancer Treatment
Jazz Pharmaceuticals recently announced that its anticancer drug Zepzelca (Lurbinectedin Injection) in combination with Atezolizumab…
New Uric Acid-Lowering Drug Urece Tablet Offers New Hope For Gout Patients
Japanese pharmaceutical company Fuji Yakuhin Co., Ltd. announced that Urece Tablet (Dotinurad Tablet), a novel…
European Medicines Agency Reassesses And Approves Leqembi
Leqembi was recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products…
Sodium Phenylbutyrate Granules: Miracle Granules For A Health Boost
Sodium phenylbutyrate is a salt derivative of 4-phenylbutyrate (4-PBA), an aromatic fatty acid with unique…
Novel Bispecific Antibody Drug IVONESCIMAB AKESO Shows Significant Efficacy In Multiple Solid Tumors
Guangzhou, China, October 15, 2023 – Ivonescimab Akeso (Kangfang Bio, HKEX: 9926.HK) today announced the…
TECVAYLI™ Approval Brings New Options For Multiple Myeloma Treatment
In October 2022, the U.S. Food and Drug Administration (FDA) granted accelerated TECVAYLI™ (teclistamab-cqyv) FDA…
What You Need to Know About Sulbactam-Durlobactam: Mechanism, Benefits, and FDA Approval
What is Sulbactam-Durlobactam? Sulbactam Durlobactam is a new and special drug combination used to combat…